G Medical Innovations Stock (NASDAQ:GMVD)
Previous Close
$0.18
52W Range
$0.14 - $13.82
50D Avg
$0.30
200D Avg
$1.78
Market Cap
$1.80M
Avg Vol (3M)
$1.24M
Beta
-1.08
Div Yield
-
GMVD Company Profile
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.
GMVD Performance
Peer Comparison
Ticker | Company |
---|---|
FEMY | Femasys Inc. |
ZJYL | Jin Medical International Ltd. |
AKYA | Akoya Biosciences, Inc. |
GCTK | GlucoTrack, Inc. |
ATRI | Atrion Corporation |
MBOT | Microbot Medical Inc. |
MHUA | Meihua International Medical Technologies Co., Ltd. |
POAI | Predictive Oncology Inc. |
LUCY | Innovative Eyewear, Inc. |
PDEX | Pro-Dex, Inc. |
NXGL | NEXGEL, Inc. |
STSS | Sharps Technology, Inc. |